# RIVFLOZA

NDC: 0169-5308
Generic name: nedosiran
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240219

FDA application: NDA215842

## Active ingredients

- NEDOSIRAN SODIUM: 80 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-5308"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-5308
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace9d4bc-4d20-4beb-9e9d-888690424833